Researchers have developed a new DNA-based therapy that could significantly lower “bad” LDL cholesterol levels without the side effects associated with traditional statin medications. This innovative treatment works by targeting a protein called PCSK9, which regulates cholesterol levels in the bloodstream. By blocking this protein, the therapy allows cells to absorb more cholesterol, potentially reducing the risk of heart disease linked to high cholesterol.

For people looking to maintain heart health as they age, this new approach could be a game changer. The therapy demonstrated an impressive ability to cut cholesterol levels by nearly 50% in animal models. This means that individuals at risk of heart disease might have a safer option to manage their cholesterol without the muscle pain and other side effects often caused by statins.

The research is still in early stages, having shown promising results in laboratory-grown liver cells and transgenic mice. The study found that a single injection of the therapy reduced cholesterol levels by 47% within just three days. While these results are encouraging, more research is needed to confirm the effectiveness and safety of this treatment in humans.

As this therapy progresses, individuals concerned about cholesterol may want to stay informed about its development. While it’s not yet available for human use, understanding new options can help you discuss cholesterol management with your healthcare provider. Meanwhile, maintaining a healthy diet and regular exercise remain essential for heart health.

Source: sciencedaily.com